The European Commission has approved the use of the probiotic Calsporin for turkeys, chickens reared for laying, ducks, geese, game birds, pigeons and ornamental birds. This is in addition to the already existing approval of Calsporin for chickens for fattening and piglets.
Calsporin (Bacillus subtilis C-3102, No. 4b1820 – gut flora stabiliser) contains live spores of Bacillus subtilis C-3102, and is with a content of 1.0 x 1010 cfu / gram highly concentrated. To meet the demands of practice Calsporin is extremely heat-stable and has proven stability in the presence of all relevant coccidiostats, therapeutic antibiotics and organic acids.
Calsporin promotes and stabilises an optimal intestinal microflora in shifting the microbial colonisation in favour of mainly Lactobacillus spp., in turn; the proportion of pathogenic bacteria such as Coliforms and Clostridium spp. will be reduced. In this context, Calsporin supports the reduction of the ammonia excretion in the faeces.
To obtain the individual EU registrations the effectiveness has been demonstrated in different tests on chickens, pigs and turkeys. The results show that Calsporin stands specifically through improved feed efficiency (up to + 5%) and higher growth (up to 4%).
Calsporin, manufactured in Japan by Calpis, is being sold and marketed in the EU by Orffa.